Endogenous control genes in prostate cells: Evaluation of gene expression using 'real-time' quantitative polymerase chain reaction

Medical Principles and Practice

Volumn 19, Issue 6, 2010, Pages 433-439

  Nna, Emmanuel ^a   Tothill, Ibtisam E ^a   Ludeman, Linmarie ^b   Bailey, Tracey ^a  

^a CRANFIELD UNIVERSITY   (United Kingdom)

^b CHELTENHAM GENERAL HOSPITAL   (United Kingdom)

Author keywords

Glucuronidase; ABL1; Control genes; Gene expression; Glucose 6 phosphate dehydrogenase; Real time quantitative polymerase chain reaction; Transcript number

Indexed keywords

ABELSON KINASE; ANTIGEN; BETA GLUCURONIDASE; COMPLEMENTARY DNA; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; RNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER GENETICS; CONTROLLED STUDY; CYTOLYSIS; DIGITAL RECTAL EXAMINATION; EVALUATION; GENE EXPRESSION; HOUSEKEEPING GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; RNA EXTRACTION; STANDARDIZATION; TISSUE SECTION; URINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUCURONIDASE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PSEUDOGENES; SPECIMEN HANDLING; TUMOR MARKERS, BIOLOGICAL;

EID: 77957672660     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320300     Document Type: Article

References (16)

1. Beillard E, Pallisgaard N van der Velden VH, Bi W, Dee R, van der Schoot E, Delabesse E, Macintyre E, Gottardi E, Saglio G, Watzinger F, Lion T, van Dongen JJ, Hokland P, Gabert J: Evaluation of candidate control genes for di-agnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR)-a Europe Against Cancer program. Leukemia 2003; 17: 1-13.
2. Gabert J, Beillard E, van der Velden VH, Bi W, Grimwade D, Pallisgaard N, Barbany G, Cazzaniga G, Cayuela JM, Cave H, Pane F, Aerts JL, De Micheli D, Thirion X, Pradel V, González M, Viehmann S, Malec M, Saglio G, van Donge JJ: Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia-a Europe Against Cancer program. Leukemia 2003; 17: 2318-2357.
3. Kaeda J, Chase A, Goldman JM: Cytogenetic and molecular monitoring of residual dis-ease in chronic myeloid leukaemia. Acta Haematol 2002; 107:64-75.
4. Isaacs JT: Molecular markers for prostate cancer metastasis: developing diagnostic methods for predicting the aggressiveness of prostate cancer. Am J Pathol 1997; 150:1511-1520.
5. Quinn ID, Henshall SM, Sutherland RL: Mo-lecular markers of prostate cancer outcome. Eur J Cancer 2005; 41: 858-887.
6. Agrawal S, Dunsmuir WD: Molecular mark-ers in prostate cancer. 1. Predicting lethality Asian J Androl 2009; 11:14-21.
7. Leonard SM, Fradet Y, Deras IL, Blasé A, Mathis J, Sheila M, Aubin J, Cancio AT, De-saulniers M, Ellis WJ, Rittenhouse H, Gros-kopf J: PCA3 molecular urine assay for pros-tate cancer in men undergoing repeat biopsy. Urology 2007; 69: 532-535.
8. Corey E, Arfman EW, Oswin MM, Melchior SW, Tindall DJ, Young CY, Ellis WJ, Vessella RL: Detection of circulating prostate cells by reverse transcriptase-polymerase chain re-action of human glandular kallikrein (Hk2) and prostate-specific antigen (PSA) mes-sages. Urology 1997; 50: 184-188.
9. Gillio-Tos A, De Marco L, Fiano V, Garcia-Bragado F, Dikshit T, Boffetta P, Merletti F: Efficient DNA extraction from 25-year-old paraffin-embedded tissues: study of 365 samples. Pathology 2007; 39:345-348.
10. Antonov J, Goldstein DR, Oberli A, Baltzer A, Pirotta M, Leischmann A, Altermatt HJ, Jaggi R: Reliable gene expression measurements from degraded RNA by quantitative real-time PCR depend on short amplicons and a proper normalization. Lab Invest 2005; 85:1040-1050.
11. Schmidt U, Fuessel S, Koch R, Baretton GB, Lohse A, Tomasetti S, Unversucht S, Froeh-ner M, Wirth MP, Meye A: Quantitative multi-gene expression profiling of primary prostate cancer. Prostate 2006; 66: 1521-1534.
12. Vichai V Kirtikara K: Sulforhodamine B colorimetric assay for cytotoxicity screen-ing. Nat Protoc 2006;1: 1112-1116.
13. Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:2002-2007.
14. Diamandis EP, Obiezu CV: Mini-review: hu-man tissue kallikrein gene family: applica-tions in cancer. Cancer Lett 2005; 224: 1-22.
15. Benedettini E, Nguyen P, Loda M: The pathogenesis of prostate cancer: from molec-ular to metabolic alterations. Diagn Pathol 2008; 14: 195-201.
16. Bustin SA, Benes V Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT: The MIQE guidelines: mini-mum information for publication of quan-titative real-time PCR experiments. Clin Chem 2009; 55:611-622.